IFP Advisors’s Akari Therapeutics AKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding AKTX
MI
IFP Advisors's AKTX Position: Q3 2026 in Review
IFP Advisors held its Akari Therapeutics (AKTX) position steady in Q3 2026 at 181 shares worth $1.68K. The position accounts for ﹤0.01% of the portfolio, ranked #4302.
IFP Advisors first reported a position in AKTX in Q4 2017 and has held it in 5 quarters since. The position peaked at $4K in Q1 2018. 13 funds tracked by Wall St. Rank hold AKTX as of Q3 2026.
- IFP Advisors held 181 shares of Akari Therapeutics worth $1.68K as of Q3 2026.
- IFP Advisors left its Akari Therapeutics share count unchanged in Q3 2026.
- Akari Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4302 holding.
- IFP Advisors first reported a position in Akari Therapeutics in Q4 2017 and has held it in 5 quarters since.
- IFP Advisors's Akari Therapeutics position peaked at $4K in Q1 2018.
- 13 funds tracked by Wall St. Rank held Akari Therapeutics as of Q3 2026.
Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.